J. Kodama

A. Hongo, Y. Hiramatsu, J. Kodama, 2006, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

Presence of human papilloma virus DNA in pelvic lymph nodes can predict unexpected recurrence of cervical cancer in patients with histologically negative lymph nodes.

A. Hongo, J. Kodama, Y. Miyagi, 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

Reverse correlation between P-glycoprotein expression and proliferative activity in endometrial adenocarcinoma.

J. Kodama, H. Okuda, M. Yoshinouchi, 1995, European journal of obstetrics, gynecology, and reproductive biology.

Antitumor effects of a soluble insulin-like growth factor I receptor in human ovarian cancer cells: advantage of recombinant protein administration in vivo.

H. Kuramoto, A. Hongo, K. Hasegawa, 2003, Cancer research.

Amplification of the mdm‐2 gene and p53 abnormalities in uterine sarcomas

J. Kodama, Y. Miyagi, A. Seki, 1997, International journal of cancer.

Association of CXCR4 and CCR7 chemokine receptor expression and lymph node metastasis in human cervical cancer.

A. Hongo, Y. Hiramatsu, J. Kodama, 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

Serum C-reactive protein as a prognostic factor in patients with epithelial ovarian cancer.

J. Kodama, Y. Miyagi, N. Seki, 1999, European journal of obstetrics, gynecology, and reproductive biology.

Placenta growth factor is abundantly expressed in human cervical squamous cell carcinoma.

J. Kodama, N. Seki, M. Yoshinouchi, 1997, European journal of gynaecological oncology.

Loss of basement membrane heparan sulfate expression is associated with tumor progression in endometrial cancer.

A. Hongo, Y. Hiramatsu, J. Kodama, 2005, European journal of gynaecological oncology.

D-dimer level as a risk factor for postoperative venous thromboembolism in Japanese women with gynecologic cancer.

A. Hongo, Y. Hiramatsu, J. Kodama, 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

Secretory leukoprotease inhibitor inhibits cell growth through apoptotic pathway on ovarian cancer.

A. Hongo, Y. Hiramatsu, J. Kodama, 2008, Oncology reports.

A pilot study of combination chemotherapy with paclitaxel, pirarubicin, and carboplatin (TPC) for endometrial carcinoma

A. Hongo, Y. Hiramatsu, J. Kodama, 2010, International Journal of Clinical Oncology.

Phase I study of chemoradiation with nedaplatin and ifosfamide in patients with advanced squamous cell carcinoma of the uterine cervix

S. Kanazawa, M. Takemoto, A. Hongo, 2007, International Journal of Gynecologic Cancer.

Efficacy and prognostic implications of administering adjuvant chemotherapy to patients with endometrial cancer that is confined to the uterus.

A. Hongo, Y. Hiramatsu, J. Kodama, 2007, European journal of obstetrics, gynecology, and reproductive biology.

Heparanase expression is an independent prognostic factor in patients with invasive cervical cancer.

A. Hongo, Y. Hiramatsu, J. Kodama, 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

The expression of vascular endothelial growth factor and transforming growth factor-beta associates with angiogenesis in epithelial ovarian cancer.

J. Kodama, H. Okuda, M. Yoshinouchi, 1997, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

Factors associated with parametrial involvement in stage IB1 cervical cancer and identification of patients suitable for less radical surgery.

A. Hongo, Y. Hiramatsu, J. Kodama, 2011, Gynecologic oncology.

Rapid and Sensitive Detection of Physical Status of Human Papillomavirus Type 16 DNA by Quantitative Real-Time PCR

A. Hongo, J. Kodama, Y. Miyagi, 2002, Journal of Clinical Microbiology.

Expression of the CXCR4 and CCR7 chemokine receptors in human endometrial cancer.

Y. Hiramatsu, J. Kodama, Hasengaowa, 2007, European journal of gynaecological oncology.

Association of CXCR 4 and CCR 7 chemokine receptor expression and lymph node metastasis in human cervical cancer

A. Hongo, Y. Hiramatsu, J. Kodama, 2007 .

Loss of cell-surface heparan sulfate expression in both cervical intraepithelial neoplasm and invasive cervical cancer.

Y. Hiramatsu, J. Kodama, Hasengaowa, 2005, Gynecologic oncology.

Elevated preoperative plasma D-dimer levels and the incidence of venous thromboembolism in Japanese females with gynecological cancer.

A. Hongo, Y. Hiramatsu, J. Kodama, 2013, Oncology letters.

Prognostic significance of the thymidine phosphorylate/dihydropyrimidine dehydrogenase ratio in invasive cervical cancer.

A. Hongo, Y. Hiramatsu, J. Kodama, 2005, European journal of obstetrics, gynecology, and reproductive biology.

Heparanase messenger RNA expression in epithelial ovarian tumor.

A. Hongo, Y. Hiramatsu, J. Kodama, 2003, International journal of molecular medicine.

Optimal surgery and diagnostic approach of stage IA2 squamous cell carcinoma of the cervix.

A. Hongo, J. Kodama, H. Okuda, 2002, European journal of obstetrics, gynecology, and reproductive biology.

α-fetoprotein-producing endometrial adenocarcinoma without an obvious hepatoid component.

A. Hongo, Y. Hiramatsu, J. Kodama, 2010, Oncology letters.

The expression of platelet-derived endothelial cell growth factor/thymidine phosphorylase associates with angiogenesis in epithelial ovarian cancer

J. Kodama, Y. Miyagi, N. Seki, 1997, International Journal of Clinical Oncology.

Vascular endothelial growth factor and platelet-derived endothelial cell growth factor expression are implicated in the angiogenesis of endometrial cancer.

A. Hongo, J. Kodama, Y. Miyagi, 2000, European journal of cancer.

Different angiogenic pathways in human cervical cancers.

J. Kodama, Y. Miyagi, N. Seki, 1998, Gynecologic oncology.

Malignant Melanoma of the Uterine Cervix: A Case Report

J. Kodama, Y. Miyagi, N. Takamoto, 1997, The journal of obstetrics and gynaecology research.

CD44 exon v6 correlates with cellular differentiation but not with progression and metastasis of cervical cancer.

J. Kodama, Y. Miyagi, N. Seki, 1998, European journal of cancer.

Detection of c-erbB-2 and FGF-3 (INT-2) gene amplification in epithelial ovarian cancer.

J. Kodama, Y. Miyagi, A. Seki, 2000, International journal of oncology.

[Mechanism of metastasis in cervical cancer].

Y. Hiramatsu, J. Kodama, 2012, Nihon rinsho. Japanese journal of clinical medicine.

Pharmacokinetics of combination chemotherapy with paclitaxel and carboplatin in a patient with advanced epithelial ovarian cancer undergoing hemodialysis.

A. Hongo, Y. Hiramatsu, J. Kodama, 2010, Oncology letters.

Coexistence of Graves' disease and struma ovarii: case report and literature review.

F. Otsuka, H. Masuyama, J. Kodama, 2001, Endocrine journal.

Expression of the serine protease hepsin and clinical outcome of human endometrial cancer.

Yuji Hiramatsu, Junichi Kodama, Hiromi Kumon, 2008, Anticancer research.

Parathyroid hormone‐related protein as a potential tumor marker: A case report of ovarian clear cell carcinoma

H. Masuyama, Y. Hiramatsu, J. Kodama, 2006, The journal of obstetrics and gynaecology research.

A‐kinase anchoring protein 3 messenger RNA expression in ovarian cancer and its implication on prognosis

K. Hasegawa, J. Kodama, T. Kudo, 2004, International journal of cancer.

Assessment of Myometrial Invasion at the Invasion Site of an Endometrial Carcinoma by Ultrasonography Along with an Intrauterine Catheter

A. Hongo, J. Kodama, Y. Miyagi, 1999, The journal of obstetrics and gynaecology research.

Correlation of presenting symptoms and patient characteristics with endometrial cancer prognosis in Japanese women

A. Hongo, Y. Hiramatsu, J. Kodama, 2005, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

Vascular endothelial growth factor is implicated in early invasion in cervical cancer.

A. Hongo, J. Kodama, Y. Miyagi, 1999, European journal of cancer.

The role of hepatocyte growth factor activator inhibitor (HAI)‐1 and HAI‐2 in endometrial cancer

A. Hongo, Y. Hiramatsu, J. Kodama, 2011, International journal of cancer.

Eradication of HPV post-surgical treatments, its correlation with specific types, types of surgery and the physical status.

K. Yamato, Y. Hiramatsu, J. Kodama, 2004, Oncology reports.

SSX expression in gynecological cancers and antibody response in patients.

A. Hongo, K. Hasegawa, Y. Hiramatsu, 2004, Cancer immunity.

Neoadjuvant Chemotherapy with Taxane and Platinum Followed by Radical Hysterectomy for Stage IB2-IIB Cervical Cancer: Impact of Histology Type on Survival

J. Kigawa, M. Shimada, J. Kodama, 2019, Journal of clinical medicine.

Hepatocyte growth factor activator inhibitor-2 (HAI-2) is a favorable prognosis marker and inhibits cell growth through the apoptotic pathway in cervical cancer.

A. Hongo, Y. Hiramatsu, J. Kodama, 2009, Annals of oncology : official journal of the European Society for Medical Oncology.

Vascular endothelial growth factor-C expression and its relationship to pelvic lymph node status in invasive cervical cancer

A. Hongo, J. Kodama, N. Seki, 2001, British Journal of Cancer.

Macrophage infiltration and angiogenesis in endometrial cancer.

A. Hongo, J. Kodama, Y. Miyagi, 2000, Anticancer research.

Angiogenesis and platelet-derived endothelial cell growth factor/thymidine phosphorylase expression in cervical cancer.

A. Hongo, J. Kodama, Y. Miyagi, 1999, International journal of oncology.

Prognostic significance of syndecan-1 expression in human endometrial cancer.

Y. Hiramatsu, J. Kodama, Hasengaowa, 2005, Annals of oncology : official journal of the European Society for Medical Oncology.

Prognostic factors in stage IB–IIB cervical adenocarcinoma patients treated with radical hysterectomy and pelvic lymphadenectomy

A. Hongo, Y. Hiramatsu, J. Kodama, 2010, Journal of surgical oncology.

The mean apparent diffusion coefficient value (ADCmean) on primary cervical cancer is a predictive marker for disease recurrence.

A. Hongo, Y. Hiramatsu, J. Kodama, 2012, Gynecologic oncology.

Prognostic factors in pathologic parametrium-positive patients with stage IB-IIB cervical cancer treated by radical surgery and adjuvant therapy.

A. Hongo, Y. Hiramatsu, J. Kodama, 2007, Gynecologic oncology.

Advanced endometrial cancer detected at 7 months after childbirth.

J. Kodama, Y. Miyagi, H. Okuda, 1997, Gynecologic oncology.

Three cases of struma ovarii underwent laparoscopic surgery with definite preoperative diagnosis.

A. Hongo, Y. Hiramatsu, J. Kodama, 2013, Acta medica Okayama.

Heparanase expression in both normal endometrium and endometrial cancer

A. Hongo, Y. Hiramatsu, J. Kodama, 2005, International Journal of Gynecologic Cancer.

Hepatocyte growth factor activator inhibitors (HAI-1 and HAI-2) are potential targets in uterine leiomyosarcoma.

A. Hongo, Y. Hiramatsu, J. Kodama, 2010, International journal of oncology.

The predictive value of measurement of SUVmax and SCC-antigen in patients with pretreatment of primary squamous cell carcinoma of cervix.

S. Kanazawa, A. Hongo, Y. Hiramatsu, 2010, Gynecologic oncology.

Measurement of the minimum apparent diffusion coefficient (ADCmin) of the primary tumor and CA125 are predictive of disease recurrence for patients with endometrial cancer.

A. Hongo, Y. Hiramatsu, J. Kodama, 2012, Gynecologic oncology.

A rare maternal gastrointestinal stromal tumor found in the second trimester of pregnancy: A case report

J. Kodama, T. Kubota, Shoko Tamada, 2020, Case reports in women's health.

Immunohistochemical evaluation of insulin-like growth factor I receptor status in cervical cancer specimens.

H. Kuramoto, A. Hongo, Y. Hiramatsu, 2008, Acta medica Okayama.

The SUVmax of 18F-FDG PET Correlates With Histological Grade in Endometrial Cancer

S. Kanazawa, A. Hongo, Y. Hiramatsu, 2009, International Journal of Gynecologic Cancer.

Thrombospondin-1 and -2 messenger RNA expression in invasive cervical cancer: correlation with angiogenesis and prognosis.

A. Hongo, J. Kodama, N. Seki, 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

The pretreatment of maximum standardized uptake values (SUVmax) of the primary tumor is predictor for poor prognosis for patients with epithelial ovarian cancer.

A. Hongo, Y. Hiramatsu, J. Kodama, 2012, Acta medica Okayama.

Risk factors for early and late postoperative complications of patients with endometrial cancer.

A. Hongo, Y. Hiramatsu, J. Kodama, 2006, European journal of obstetrics, gynecology, and reproductive biology.

Fat accumulation in adipose tissues as a risk factor for the development of endometrial cancer.

A. Hongo, Y. Hiramatsu, J. Kodama, 2011, Oncology reports.

Angiogenesis and platelet-derived endothelial cell growth factor/thymidine phosphorylase expression in endometrial cancer.

A. Hongo, J. Kodama, Y. Miyagi, 1999, International Journal of Oncology.

Immunohistochemical analysis of P-glycoprotein expression in diverse histological types of epithelial ovarian tumors.

J. Kodama, H. Okuda, M. Yoshinouchi, 1994, Acta Medica Okayama.

Measurement of SUVmax plus ADCmin of the primary tumour is a predictor of prognosis in patients with cervical cancer

A. Hongo, Y. Hiramatsu, J. Kodama, 2012, European Journal of Nuclear Medicine and Molecular Imaging.

Postoperative decreased levels of D-dimer in patients with gynecologic cancer with enoxaparin and fondaparinux thromboprophylaxis

Y. Hiramatsu, J. Kodama, T. Kusumoto, 2013, Molecular and clinical oncology.

Changes in soluble fibrin levels during the perioperative period of gynecologic cancer surgery.

A. Hongo, Y. Hiramatsu, J. Kodama, 2012, Oncology letters.

Stage IB1 cervical cancer patients with an MRI-measured tumor size < or = 2 cm might be candidates for less-radical surgery.

A. Hongo, Y. Hiramatsu, J. Kodama, 2013, European journal of gynaecological oncology.

A close correlation between c-erbB-2 gene amplification and local progression in endometrial adenocarcinoma.

J. Kodama, Y. Miyagi, A. Seki, 1998, European journal of gynaecological oncology.

Multivariate assessment of cervical invasion of endometrial carcinoma: Comparison of transvaginal ultrasonography, hysteroscopy, and magnetic resonance imaging

J. Kodama, Y. Miyagi, T. Kudo, 2006, International Journal of Clinical Oncology.

Hepsin inhibits the cell growth of endometrial cancer.

A. Hongo, Y. Hiramatsu, J. Kodama, 2008, International journal of molecular medicine.

Complications and obstetric outcomes after laser conization during pregnancy.

A. Hongo, Y. Hiramatsu, J. Kodama, 2010, European journal of gynaecological oncology.

Hepsin shows inhibitory effects through apoptotic pathway on ovarian cancer cell lines.

A. Hongo, Y. Hiramatsu, J. Kodama, 2006, International journal of oncology.

Prognostic significance of stromal versican expression in human endometrial cancer.

A. Hongo, Y. Hiramatsu, J. Kodama, 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

Prognostic outcomes of total laparoscopic hysterectomy vs. total abdominal hysterectomy for early-stage endometrial carcinoma

J. Kodama, Naoyuki Ida, K. Morikawa, 2020 .